ILiAD Biotechnologies Announces Lancet Microbe Publication of BPZE1 Phase 2b Clinical Results in Human Challenge Model December 3, 2025 Study Highlights First-ever Demonstration of Protection Against B. pertussis Colonization in Humans
Options Appoints Former Exergy / ICE Sales Director, Bob Coletti as Sales Director Strategic Accounts December 3, 2025 Options Technology, a leading provider of high-performance trading infrastructure and market data solutions, today announced the appointment of Bob Coletti as Sales Director, Strategic Accounts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251203430077/en/ With a career spanning senior commercial roles across the financial technology ecosystem, Bob has built a reputation for cultivating [...]
LumRisk Announces Strategic Reset and USD 5 Million Capital Commitment to Accelerate Its Transformation Toward an AI-Driven QIS and Multi-Asset Platform December 3, 2025 LumRisk today announced a major milestone in its evolution, with the approval and implementation of a comprehensive corporate reset. This includes the restructuring of legacy obligations and the reinforcement of the company’s balance sheet. These measures establish a strong foundation for a new phase of accelerated global growth across LumRisk’s core domains: Quantitative Investment Strategies [...]
TITAN Honored With ESG Transparency Award 2025 for Excellence in Disclosure December 3, 2025 TITAN Group (Brussels:TITC) has been recognized for setting a benchmark in transparent ESG reporting, earning the prestigious ESG Transparency Award 2025 from the EUPD Group, Europe’s leading market research institute. This marks the second consecutive year TITAN has received this distinction, with its score rising from 89% to 95%, reinforcing its reputation for openness, accountability, [...]
Taiho Oncology Europe announces the launch of Lytgobi®▼ (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced or metastatic cholangiocarcinoma1 December 3, 2025 Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK2
From Tickets to Takeoff: Gig-Tripping Made Seamless with viagogo and Booking.com December 3, 2025 viagogo, the leading global secondary ticketing marketplace, today announced a new partnership with Booking.com, one of the world’s largest travel platforms, to make event-going even more seamless. Through the industry-first partnership, fans purchasing tickets on viagogo can now easily add hotels, flights, rental cars, attractions, and more through Booking.com – turning a bucket list gig [...]
Coremont Secures $40M Strategic Investment from Funds Managed by Blue Owl to Accelerate Innovation in Portfolio Analytics December 3, 2025 Coremont, a leading provider of real-time, multi-asset class portfolio management software and analytics, today announced a $40 million strategic growth investment from funds managed by Blue Owl Capital (NYSE: OWL), a leading asset manager with $295 billion in assets under management. The investment recognizes Coremont’s position as a critical infrastructure partner to asset managers, hedge [...]
Reply Awarded a 2025 AWS Partner of the Year Award December 3, 2025 Reply recognized as winner for EMEA Partner of the Year, Industry Energy & Utilities, one of many AWS Partners around the globe that help their customers drive innovation
Ramify Partners with ROYC to Enrich its Private Markets Offer Under Its Own Brand December 3, 2025 ROYC, the market-leading European B2B platform for sourcing, structuring, and distributing private-market investments, and Ramify, the next-generation private wealth management platform based in France, today announced a strategic collaboration enabling Ramify to broaden its private-markets offering through a curated range of high-quality private-market funds and programs. The partnership enables Ramify to distribute, and scale modern [...]
NIKE, Inc. Announces Senior Leadership Changes to Accelerate “Win Now” Actions December 2, 2025 NIKE, Inc. (NYSE:NKE) today shared the following note with employees regarding changes to its Senior Leadership Team. // Team, I’d like to share some important changes to our Senior Leadership Team (SLT) that further remove layers and continue to bring us closer to athletes* and the marketplace. We’re establishing the role of EVP, Chief Operating [...]